Key result
A rational clinical approach to evaluating asymptomatic hyperCKemia helps reveal identifiable underlying causes and addresses controversies regarding diagnostic testing yield.
Provides a rational clinical approach for evaluating patients with asymptomatic hyperCKemia to identify underlying causes.
Answers are grounded in this paper and cite their sources.
May inform evaluation of asymptomatic hyperCKemia to identify causes; leaves open prospective validation of testing yield.
Neuromuscular clinicians are frequently asked to evaluate patients referred for asymptomatic elevations in creatine kinase (CK), a catalytic enzyme that combines creatine and ATP to form phosphocreatine and ADP. This reaction is crucial for cellular energy generation and metabolism. This laboratory finding, often referred to in simplified lexicon as asymptomatic hyperCKemia, continues to generate controversy at several levels, including definition, the extent of evaluation, and the yield of diagnostic testing. In this review, we summarize the literature based on series of patients with asymptomatic hyperCKemia and provide a rational clinical approach to reveal identifiable underlying causes.
No takes yet. Share an insight, caveat, or question.
Silvestri et al. (2012) conducted a review in Asymptomatic hyperCKemia. A rational clinical approach to evaluating asymptomatic hyperCKemia helps reveal identifiable underlying causes and addresses controversies regarding diagnostic testing yield.
Synapse has enriched 10 related papers. Consider them for comparative context: